228 related articles for article (PubMed ID: 37026060)
1. Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1.
Hu YL; Zhang LQ; Liu XQ; Ye W; Zhao YX; Zhang L; Qiang ZX; Zhang LX; Lei YF; Jiang DB; Cheng LF; Zhang FL
Front Cell Infect Microbiol; 2023; 13():1121163. PubMed ID: 37026060
[TBL] [Abstract][Full Text] [Related]
2. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
J Virol; 2017 May; 91(10):. PubMed ID: 28250124
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside-Modified mRNA Vaccines Protect IFNAR
Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
[TBL] [Abstract][Full Text] [Related]
4. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
[TBL] [Abstract][Full Text] [Related]
5. Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice Models.
Aligholipour Farzani T; Földes K; Hanifehnezhad A; Yener Ilce B; Bilge Dagalp S; Amirzadeh Khiabani N; Ergünay K; Alkan F; Karaoglu T; Bodur H; Ozkul A
Viruses; 2019 Mar; 11(3):. PubMed ID: 30857305
[TBL] [Abstract][Full Text] [Related]
6. Co-Delivery Effect of CD24 on the Immunogenicity and Lethal Challenge Protection of a DNA Vector Expressing Nucleocapsid Protein of Crimean Congo Hemorrhagic Fever Virus.
Aligholipour Farzani T; Hanifehnezhad A; Földes K; Ergünay K; Yilmaz E; Hashim Mohamed Ali H; Ozkul A
Viruses; 2019 Jan; 11(1):. PubMed ID: 30658445
[TBL] [Abstract][Full Text] [Related]
7. A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model.
Hawman DW; Ahlén G; Appelberg KS; Meade-White K; Hanley PW; Scott D; Monteil V; Devignot S; Okumura A; Weber F; Feldmann H; Sällberg M; Mirazimi A
Nat Microbiol; 2021 Feb; 6(2):187-195. PubMed ID: 33257849
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
[TBL] [Abstract][Full Text] [Related]
9. Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38.
Mishra AK; Moyer CL; Abelson DM; Deer DJ; El Omari K; Duman R; Lobel L; Lutwama JJ; Dye JM; Wagner A; Chandran K; Cross RW; Geisbert TW; Zeitlin L; Bornholdt ZA; McLellan JS
J Virol; 2020 Mar; 94(8):. PubMed ID: 31996434
[TBL] [Abstract][Full Text] [Related]
10. Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virus.
Garrison AR; Moresco V; Zeng X; Cline CR; Ward MD; Ricks KM; Olschner SP; Cazares LH; Karaaslan E; Fitzpatrick CJ; Bergeron É; Pegan SD; Golden JW
Nat Commun; 2024 Feb; 15(1):1722. PubMed ID: 38409240
[TBL] [Abstract][Full Text] [Related]
11. Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge.
Zivcec M; Safronetz D; Scott DP; Robertson S; Feldmann H
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006628. PubMed ID: 30011277
[TBL] [Abstract][Full Text] [Related]
12. A competitive ELISA for species-independent detection of Crimean-Congo hemorrhagic fever virus specific antibodies.
Schuster I; Mertens M; Köllner B; Korytář T; Keller M; Hammerschmidt B; Müller T; Tordo N; Marianneau P; Mroz C; Rissmann M; Stroh E; Dähnert L; Hammerschmidt F; Ulrich RG; Groschup MH
Antiviral Res; 2016 Oct; 134():161-166. PubMed ID: 27623345
[TBL] [Abstract][Full Text] [Related]
13. Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.
Zivcec M; Guerrero LIW; Albariño CG; Bergeron É; Nichol ST; Spiropoulou CF
Antiviral Res; 2017 Oct; 146():112-120. PubMed ID: 28842265
[TBL] [Abstract][Full Text] [Related]
14. Development of a Novel Multi-Epitope Vaccine Against Crimean-Congo Hemorrhagic Fever Virus: An Integrated Reverse Vaccinology, Vaccine Informatics and Biophysics Approach.
Tahir Ul Qamar M; Ismail S; Ahmad S; Mirza MU; Abbasi SW; Ashfaq UA; Chen LL
Front Immunol; 2021; 12():669812. PubMed ID: 34220816
[TBL] [Abstract][Full Text] [Related]
15. Multiplex Assay for Simultaneous Detection of Antibodies against Crimean-Congo Hemorrhagic Fever Virus Nucleocapsid Protein and Glycoproteins in Ruminants.
Hoste ACR; Djadjovski I; Jiménez-Clavero MÁ; Rueda P; Barr JN; Sastre P
Microbiol Spectr; 2023 Feb; 11(2):e0260022. PubMed ID: 36815788
[TBL] [Abstract][Full Text] [Related]
16. Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever.
Rodriguez SE; Cross RW; Fenton KA; Bente DA; Mire CE; Geisbert TW
Sci Rep; 2019 May; 9(1):7755. PubMed ID: 31123310
[TBL] [Abstract][Full Text] [Related]
17. Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model.
Hawman DW; Meade-White K; Leventhal S; Appelberg S; Ahlén G; Nikouyan N; Clancy C; Smith B; Hanley P; Lovaglio J; Mirazimi A; Sällberg M; Feldmann H
Mol Ther; 2023 Feb; 31(2):387-397. PubMed ID: 36184852
[TBL] [Abstract][Full Text] [Related]
18. Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse model.
Kempster S; Hassall M; Graham V; Kennedy E; Findlay-Wilson S; Salguero FJ; Bagci B; Elaldi N; Oz M; Tasseten T; Charlton FW; Barr JN; Fontana J; Duru C; Ezeajughi E; Matejtschuk P; Arnold U; Adedeji Y; Mirazimi A; Hewson R; Dowall S; Almond N
Virus Res; 2024 Aug; 346():199409. PubMed ID: 38815869
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Inhibitors of Pathogenic Crimean-Congo Hemorrhagic Fever Virus Strains Using Virus-Like Particles.
Zivcec M; Metcalfe MG; Albariño CG; Guerrero LW; Pegan SD; Spiropoulou CF; Bergeron É
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004259. PubMed ID: 26625182
[TBL] [Abstract][Full Text] [Related]
20. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015.
Palomar AM; Portillo A; Santibáñez S; García-Álvarez L; Muñoz-Sanz A; Márquez FJ; Romero L; Eiros JM; Oteo JA
Enferm Infecc Microbiol Clin; 2017; 35(6):344-347. PubMed ID: 28291670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]